PCE Oncology 2022 Spring

Share

Program Content

Activities

Strategies for CLL/SLL and MCL
Evolving Treatment Strategies for CLL/SLL and MCL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

How I Manage My Patients With MCL, CLL, and SLL
How I Manage My Patients With MCL, CLL, and SLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2022

Expires: June 15, 2023

Evolving Treatment Strategies for CLL/SLL and MCL
Evolving Treatment Strategies for CLL/SLL and MCL
PCE On Demand Live Presentation
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

Activities

Advanced Urothelial Cancer
Keeping Up With New Concepts in Managing Advanced Urothelial Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Using New Treatment Options for Patients With Advances Urothelial Cancer
Using New Treatment Options for Patients With Advances Urothelial Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Keeping Up With New Concepts in Managing Advanced Urothelial Cancer
Keeping Up With New Concepts in Managing Advanced Urothelial Cancer
PCE On Demand Live Presentation
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

Activities

Advanced Gastric Cancer
Targeted and Immunotherapies in Advanced Gastric Cancer: Key Data on Treatment Selection and AE Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Updates on Targeted and Immunotherapies for Advanced Gastric Cancer
Updates on Targeted and Immunotherapies for Advanced Gastric Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Targeted and Immunotherapies in Advanced Gastric Cancer: Key Data on Treatment Selection and AE Management
Targeted and Immunotherapies in Advanced Gastric Cancer: Key Data on Treatment Selection and AE Management
PCE On Demand Live Presentation
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

Activities

HR+/HER2- Breast Cancer
CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Considerations When Managing HR+/HER2- Breast Cancer With CDK4/6 Inhibitors
Considerations When Managing HR+/HER2- Breast Cancer With CDK4/6 Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Nursing Considerations for CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Nursing Considerations for CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2022

Expires: June 29, 2023

CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use
CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use
Patient Simulation
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2022

Expires: September 15, 2023

Activities

NSCLC Actionable Biomarkers
Keeping Up in NSCLC: Actionable Biomarkers and Their Impact on Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

The Importance of Biomarker Testing in NSCLC and Impact on Treatment
The Importance of Biomarker Testing in NSCLC and Impact on Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Keeping Up in NSCLC: Actionable Biomarkers and Their Impact on Treatment
Keeping Up in NSCLC: Actionable Biomarkers and Their Impact on Treatment
PCE On Demand Live Presentation
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

Activities

Optimizing Immune Checkpoint Inhibitor
Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Optimizing Immunotherapy for Advanced Non-Small-Cell Lung Cancer in Today’s Patients
Optimizing Immunotherapy for Advanced Non-Small-Cell Lung Cancer in Today’s Patients
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: An Update from ASCO
Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: An Update from ASCO
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2022

Expires: June 26, 2023

Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer
Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2022

Expires: June 29, 2023

Transforming the Care of Patients with Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
Transforming the Care of Patients with Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
PCE On Demand Live Presentation
Congratulations: You achieved a completion on 04/09/2022

Released: July 14, 2022

Expires: July 13, 2023

Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
Transforming the Care of Patients With Non-Small-Cell Lung Cancer: Optimizing Immune Checkpoint Inhibitor Therapy
Patient Simulation
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2022

Expires: August 16, 2023

2022 Spring PCE Oncology Conference Series PDF Resource
2022 Spring PCE Oncology Conference Series PDF Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Activities

Advances in Gynecologic Cancers
Advances in Gynecologic Cancers: A New Era in Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Thoughts on Recent Advances With Precision Medicine in Cervical Cancer
Thoughts on Recent Advances With Precision Medicine in Cervical Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

The Role of PAs in Clinical Care: How I Care for Women With Gynecologic Cancers
The Role of PAs in Clinical Care: How I Care for Women With Gynecologic Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

What You Should Know About Recent Advances in Endometrial Cancer
What You Should Know About Recent Advances in Endometrial Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

Advances in Gynecologic Cancers: A New Era in Treatment
Advances in Gynecologic Cancers: A New Era in Treatment
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

Activities

Focus on PARP Inhibitors
Progress in Prostate Cancer: A Focus on PARP Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2022

Expires: April 21, 2023

Incorporating PARP Inhibitors for mCRPC: A Nursing Perspective
Incorporating PARP Inhibitors for mCRPC: A Nursing Perspective
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

A Nursing Perspective on PARP Inhibitors in Prostate Cancer
A Nursing Perspective on PARP Inhibitors in Prostate Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2022

Expires: June 29, 2023

Progress in Prostate Cancer: A Focus on PARP Inhibitors
Progress in Prostate Cancer: A Focus on PARP Inhibitors
Patient Simulation
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2022

Expires: August 16, 2023

Faculty

cover img faculity

Sidharth Anand, MD

Assistant Professor of Medicine                                                                                                                            Division of Hematology - Oncology                                                                                                                              UCLA David Geffen School of Medicine                                                                                                                          Los Angeles, California

cover img faculity

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Rachel Frankenthal, PA-C, MPH

Physician Assistant
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

cover img faculity

Elizabeth Krueger, NP

Nurse Practitioner
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Julia LaBarbera, MSN, RN, AGACNP-BC

  • Nurse Practitioner
    Division of Hematology/Oncology
    Department of Medicine
    University of California, Los Angeles
    Santa Monica, California

cover img faculity

Julia A. LaBarbera, MSN, RN, AGACNP-BC

Breast Oncology
UCLA Medical Center
Los Angeles, California

cover img faculity

Brenda Martone, MSN, ANP-BC, AOCNP

Nurse Practitioner
Northwestern Medicine
Chicago, Illinois

cover img faculity

Sandip P. Patel, MD

Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California San Diego
San Diego, California

cover img faculity

Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

cover img faculity

Julia Rotow, MD

Medical Oncologist
Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Cristina Salabao, MSN, FNP-C, AOCNP

Nurse Practitioner
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Ritu Salani, MD, MBA

Professor and Division Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

cover img faculity

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

ProCE Banner

Supporters

Astellas

Astellas

AstraZeneca

AstraZeneca

Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb

Daiichi Sankyo, Inc.

Genentech, a member of the Roche Group

Genentech, a member of the Roche Group

GlaxoSmithKline

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Lilly

Lilly

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc.

Sanofi

Sanofi

Seagen and Astellas

Seagen Inc.